Colorectal Cancer clinical trials

426 recruiting studies in the US for colorectal cancer, cancer of the colon or rectum.

Colorectal cancer trials lean early-phase — many Phase 1 and Phase 1/2 studies of targeted drugs and immunotherapy — plus screening and prevention research. Treatment trials often depend on tumor markers such as KRAS, BRAF or MSI status and how many prior treatments you've had. Screening studies, like at-home test programs, are often open to people without cancer.